Announced
Completed
Financials
Tags
Single Bidder
Friendly
allergy treatment
Private Equity
Cross Border
Majority
Private
asthma
United States
Health Care Services
Acquisition
Completed
Synopsis
Waypoint Capital, an entrepreneurial private investment firm, completed the acquisition of a 70% stake in Allergy Partners, the largest US group of single-specialty allergy and asthma practices. Financial terms were not disclosed. "We are excited to be partnering with Waypoint Capital as Allergy Partners looks to increase access to our services for even more patients across the country. Our mission is to be leaders in the development and delivery of high-quality health care for patients with asthma and allergic disease. Our partnership with Waypoint will further that mission as we continue to execute on our strategic initiatives, further build our vast care network, and promote continued research and innovation in the field of allergy and asthma care," David Brown, Allergy Partners CEO.
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.